Shuttle Pharmaceuticals Holdings Net Income

The latest net income for SHPH is $-10M as of June 2026. That compares with $-12M in the prior-year period — up 15.5% year over year. That is below the sector sector average of $89M. Investors often review this figure alongside Shuttle Pharmaceuticals Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, SHPH's net income moved from $-12M to $-10M — a 15.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Shuttle Pharmaceuticals Holdings's operating scale or balance-sheet position.

Against its sector companies, SHPH currently prints $-10M for net income, while the sector average sits near $89M. That is roughly 111.5% below the sector mean. Large gaps often invite a closer look at Shuttle Pharmaceuticals Holdings's growth, margins, and balance sheet.

A net income figure of $-10M for SHPH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $89M. Explore the charts below for those layers of context.

After noting SHPH's net income ($-10M), review year-over-year change from $-12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.